Engineered tissue inhibitor of metalloproteinases-3 variants resistant to endocytosis have prolonged chondroprotective activity

Doherty, Christine M., Visse, Robert, Dinakarpandian, Deendayal, Strickland, Dudley K., Nagase, Hideaki and Troeberg, Linda ORCID: https://orcid.org/0000-0003-0939-4651 (2016) Engineered tissue inhibitor of metalloproteinases-3 variants resistant to endocytosis have prolonged chondroprotective activity. The Journal of Biological Chemistry, 291 (42). pp. 22160-22172. ISSN 0021-9258

[thumbnail of JBC_Doherty_etal_2016]
Preview
PDF (JBC_Doherty_etal_2016) - Published Version
Available under License Creative Commons Attribution.

Download (2MB) | Preview

Abstract

Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a central inhibitor of matrix-degrading and sheddase families of metalloproteinases. Extracellular levels of the inhibitor are regulated by the balance between its retention on the extracellular matrix and its endocytic clearance by the scavenger receptor low density lipoprotein receptor-related protein 1 (LRP1). Here, we used molecular modeling to predict TIMP-3 residues potentially involved in binding to LRP1 based on the proposed LRP1 binding motif of 2 lysine residues separated by about 21 Å and mutated the candidate lysine residues to alanine individually and in pairs. Of the 22 mutants generated, 13 displayed a reduced rate of uptake by HTB94 chondrosarcoma cells. The two mutants (TIMP-3 K26A/K45A and K42A/K110A) with lowest rates of uptake were further evaluated and found to display reduced binding to LRP1 and unaltered inhibitory activity against prototypic metalloproteinases. TIMP-3 K26A/K45A retained higher affinity for sulfated glycosaminoglycans than K42A/K110A and exhibited increased affinity for ADAMTS-5 in the presence of heparin. Both mutants inhibited metalloproteinase-mediated degradation of cartilage at lower concentrations and for longer than wild-type TIMP-3, indicating that their increased half-lives improved their ability to protect cartilage. These mutants may be useful in treating connective tissue diseases associated with increased metalloproteinase activity.

Item Type: Article
Additional Information: © 2016 by The American Society for Biochemistry and Molecular Biology, Inc.
Uncontrolled Keywords: genetics,genetics,metabolism,cell line, tumor,genetics,endocytosis,genetics,metabolism,humans,genetics,genetics,genetics
Related URLs:
Depositing User: LivePure Connector
Date Deposited: 04 Jan 2019 12:30
Last Modified: 03 Aug 2023 12:30
URI: https://ueaeprints.uea.ac.uk/id/eprint/69441
DOI: 10.1074/jbc.M116.733261

Downloads

Downloads per month over past year

Actions (login required)

View Item View Item